Intensive blood pressure and cholesterol control therapies were not tied to lower risk of cognitive decline
(dailyRx News) Type 2 diabetes has been linked to dementia and cognitive decline in older adults. A recent study examined whether intensive blood pressure goals and fibrate therapy could help.
Type 2 diabetes is a condition in which the body becomes resistant to insulin, a natural substance that regulates blood sugar.
The researchers found in two study arms that intensive treatment goals for high blood pressure and adding a fibrate medication to statin treatment of high cholesterol did not prevent cognitive decline and brain volume loss in diabetes patients compared to standard treatment.
Read more from RxWiki HERE.